Literature DB >> 85807

Inhibition by protease inhibitors of binding of adrenal and sex steroid hormones.

M E Baker, D A Vaughn, D D Fanestil.   

Abstract

Binding of steroid hormones is inhibited by protease inhibitors and substrates. The protease inhibitors phenylmethyl sulphonylfluoride, tosyl-lysine chloromethyl ketone, and tosylamide-phenylethyl-chloromethyl ketone and the protease substrates tosyl arginine methyl ester and tryptophan methyl ester eliminate specific binding of aldosterone, dexamethasone, dihydrotestosterone, estrogen, and progesterone to their respective receptors. These protease inhibitors and substrates also inhibit binding of progesterone to the 20,000 molecular weight mero-receptor formed from the progesterone receptor in chick oviduct. The binding of estradiol to rat alpha-fetoprotein is inhibited by the protease inhibitors and substrates but not by tryptophan or tryptophan amide, indicating the importance of an ester structure in the inhibition of steroid binding. Our results suggest that all steroid hormone receptors have a site with both common structural features and a role in the regulation of steroid hormone binding.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 85807     DOI: 10.1002/jss.400090312

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  4 in total

1.  Similarity between human retinoic acid receptor and Escherichia coli homoserine kinase.

Authors:  M E Baker
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

2.  Estradiol receptor has proteolytic activity that is responsible for its own transformation.

Authors:  G A Puca; C Abbondanza; V Nigro; I Armetta; N Medici; A M Molinari
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 3.  Influence of proteinase inhibitors on glucocorticoid receptor properties: recent progress and future perspectives.

Authors:  J R Hubbard; M Kalimi
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

4.  Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management.

Authors:  Marco de Tubino Scanavino
Journal:  Adv Urol       Date:  2011-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.